swiss medicaXXI century S.A.Arthritis can make ordinary movement difficult: walking, climbing stairs, using the hands, sleeping comfortably, or staying active at work. Standard arthritis care remains the foundation of treatment, but some patients continue to have pain, stiffness, or limited mobility despite medication, physiotherapy, lifestyle measures, or injections.
In this context, stem cell therapy for arthritis is being explored as a supportive regenerative approach that may help improve the joint microenvironment and reduce inflammation in carefully evaluated patients.
What Is Stem Cell Therapy for Arthritis?
Stem cell therapy for arthritis is a regenerative approach in which mesenchymal stromal cells (MSCs) are introduced into or near an affected joint to reduce inflammation, support tissue, and ease pain.
At Swiss Medica, only adult multipotent MSCs are used—most often donor cells from umbilical cord and placental tissue and, in selected cases, the patient’s own cells from bone marrow or adipose tissue. Embryonic, induced pluripotent, and hematopoietic stem cells are not used.
Three questions patients frequently ask during consultations:
| How does stem cell therapy for arthritis work? | Does it help cartilage? | How can it actually help me? |
| MSCs release signaling molecules — growth factors, cytokines, and exosomes — that influence the local joint environment. | MSCs may support cells present in cartilage and surrounding tissue but do not directly rebuild lost cartilage. | This is mainly achieved by reducing inflammation in the joint and supporting the local tissue environment, which together may ease the pain and improve mobility. The anti-inflammatory effect is one of the better-documented mechanisms in MSC clinical studies, particularly in knee osteoarthritis. |
How Stem Cells May Support Joint Health
Instead of directly replacing damaged cells, MSCs act mainly through paracrine activity—releasing biologically active molecules that influence the cells around them. In an arthritic joint, their effects may translate into modulation of the inflammatory response, support for repair processes through growth factor release, a more favorable environment for chondrocytes, and improved cell-to-cell communication. However, effects vary between patients and types of arthritis.
Which Types of Arthritis Are Commonly Treated?
“Arthritis” covers a wide range of joint disorders. MSC-based stem cell injections for arthritis have been studied across several forms of the condition, including
- Osteoarthritis (OA)—the most studied indication, particularly in the knee, hip, shoulder, ankle, and small joints of the hand.
- Rheumatoid arthritis (RA)—an autoimmune condition in which a person’s immune cells attack and destroy their joints. Stem cell treatment for rheumatoid arthritis is investigated for its potential to help regulate the immune system and decrease inflammation.
- Psoriatic arthritis—a form of autoimmune joint inflammation linked to psoriasis
- Arthrosis and joint degeneration—broader degenerative changes in cartilage and joint structures.
- Osteochondrosis—affecting both bone and cartilage, especially in younger patients.
The knee, hip, and shoulder are the most common treatment sites.
Get a free online consultation
Want to understand whether you may be eligible for stem cell therapy for arthritis? Send the diagnosis and recent medical details to our team. Doctors will review the case and prepare a personalized treatment recommendation with an estimated cost range.
Medical Advisor, Swiss Medica doctor
Can Stem Cell Therapy Reverse Arthritis?
The short answer is no. No responsible clinic can promise to completely reverse arthritis, and any claim to the contrary should be treated with caution.
Why Complete Reversal Cannot Be Promised
Arthritis, especially advanced osteoarthritis, involves long-term structural changes in cartilage, bone, and soft tissue. While MSCs have the potential to influence repair processes, in real-world clinical settings they do not regrow a worn-out joint. As described on our stem cell treatment procedure page, MSC therapy is best understood as a way to enhance the body’s natural healing capacity—not a miracle cure.
What Improvement May Look Like for Patients
Realistic improvements sometimes reported after stem cell treatment for arthritis include reduced pain (especially during activity), less morning stiffness, better range of motion, easier walking, and reduced reliance on pain medication. Outcomes vary depending on type and stage of arthritis, age, weight, and overall health.
When Joint Damage May Be Too Advanced
When cartilage is essentially absent, the joint space has collapsed, or the bone has undergone significant remodeling, MSC therapy is unlikely to deliver meaningful benefits, and joint replacement may be more appropriate.
How Effective Is Stem Cell Therapy for Arthritis?
Effectiveness in arthritis is usually measured by practical changes: less pain during movement, less morning stiffness, better walking tolerance, and easier daily activity.
Current research, especially in knee osteoarthritis, suggests that some patients may experience these improvements after MSC-based treatment. But the response is not the same for everyone, and the goal is symptom relief and functional support, not complete restoration of a damaged joint.
What Recent Research Suggests
Recent research gives an encouraging picture, especially for knee osteoarthritis. A 2025 meta-analysis of randomized controlled trials involving over 500 patients found that intra-articular MSC injections significantly improved pain, stiffness, and physical function at 6- and 12-month follow-up. These improvements were measured using standard medical questionnaires that assess pain, daily activity, and joint function, with the strongest effects seen in adipose-derived cells and higher doses.
At the same time, the evidence is not strong enough to promise the same result for every patient. A 2025 systematic review found that stem cell injections for arthritis of the knee may improve pain and function compared with a placebo for up to six months, but the overall certainty of the evidence was low.
Another 2026 analysis also reported improvements in osteoarthritis pain scores without a higher rate of adverse events.
Swiss Medica Results
In our clinical experience with arthritis and other musculoskeletal conditions, patients most often describe changes that can be felt in daily life: less joint pain, reduced swelling, easier walking, better flexibility, and more confidence during movement. In different patient stories, these changes helped people return to activities such as cycling, skiing, yoga, tennis, strength training, or simply walking and climbing stairs with less discomfort.
Some patients also come to Swiss Medica hoping to postpone joint replacement surgery. While results vary and depend on the stage of joint damage, overall health, lifestyle, and individual response to therapy, several of our patients have reported staying active for longer and delaying surgery after treatment.
Jonathan Experience
Jonathan had lived with hip arthritis for around 20 years, but in the last 1–2 years the pain had started to affect everyday life, including family barbecues where standing by the grill became difficult. After supportive physiotherapy, MBST therapy, and stem cell treatment at Swiss Medica, he noticed early relief and said:
“I feel good. I feel a lot looser, and I haven’t had any pain today. It’s still early days, but I’m already noticing a difference. My hope is that the treatment will help me stay active, improve my mobility, and put off a hip replacement for as long as possible.”
More real Swiss Medica patient stories and video reviews are available on the Swiss Medica YouTube channel.
Why Treatment Results Can Differ
Several factors shape the response to MSC therapy, which is why outcomes vary between patients with the same diagnosis:
| Factor | Why it matters |
| Stage of arthritis | Earlier stages with preserved joint structure tend to respond better. |
| Cell type and source | Donor vs. autologous cells from different tissues have different profiles. |
| Delivery method and dose | Intra-articular, intravenous, or combined approaches affect outcomes. |
| Supportive therapies | Physiotherapy and rehabilitation often reinforce results. |
| Patient factors | Age, weight, and overall health all play a role. |
This is why we discuss expected outcomes individually, based on the patient’s diagnosis, imaging results, general health, and stage of joint damage.
How Swiss Medica Evaluates Patient Progress
This individualized approach extends beyond the initial consultation.
Each patient is monitored throughout treatment using validated questionnaires for pain and joint function, with imaging added when clinically indicated.
A free follow-up check is offered at 3–6 months, allowing the medical team to track real improvement, fine-tune supportive therapies, and adjust expectations when needed.
Who May Be a Candidate for Treatment?
Whether or not a patient is eligible for stem cell therapy is decided on a case-by-case basis after reviewing their medical history, current symptoms, imaging results, and laboratory tests. There are no fixed inclusion criteria that apply universally, and excellent overall health is not a prerequisite.
Patients Seeking Alternatives to Painkillers or Steroid Injections
Long-term NSAID use and repeated corticosteroid injections can cause side effects, and many patients want to reduce dependence on these medications. Regenerative approaches offer an alternative that addresses inflammation through different biological mechanisms.
Patients Trying to Delay Joint Replacement Surgery
In selected cases—for patients with moderate joint degeneration who are not yet ready for replacement or for those who cannot undergo surgery for medical reasons —stem cell therapy for arthritis can help by reducing symptoms enough to improve quality of life and, in some cases, delay the need for joint replacement. It is discussed as a possible option after individual medical assessment, and it does not replace surgery when the procedure is clearly indicated.
When Stem Cell Therapy May Not Be Recommended
Treatment is generally not recommended when:
- the joint is severely deteriorated and surgical replacement is clearly indicated
- there is an active infection, especially in or near the target joint;
- there is an active malignancy or recent history of certain cancers;
- the patient is pregnant or breastfeeding;
- there are uncontrolled systemic conditions making any intervention unsafe.
At Swiss Medica, each case is reviewed individually, with transparent discussion of expected benefits and limitations.
What Happens During Treatment at Swiss Medica?
In our clinic, the stem cell therapy for arthritis procedure combines medical evaluation, cell-based treatment, and supportive care. A detailed overview is available on our stem cell therapy step-by-step page. Here we provide a brief summary.
Medical Evaluation and Personalized Treatment Plan
On arrival, patients are examined by a multidisciplinary team that may include cardiologists, neurologists, endocrinologists, and rehabilitation specialists. Existing imaging and lab results are reviewed, and any additional safety checks are performed. Doctors then prepare an individualized plan specifying cell product, dose, delivery route, and supportive therapies.
What Happens During Treatment?
Want to know what the treatment journey looks like before arrival? From the first consultation to follow-up after discharge, our team explains each step, helps with planning, and supports patients throughout their stay at the clinic.
Learn more about what to expect during stem cell therapy.
Cell Preparation, Injection Procedures, and Supportive Care
Before administration, the cell product is prepared and checked in controlled laboratory conditions. At Swiss Medica, MSC-based products are tested for identity, viability, sterility, and possible contamination, including bacterial, fungal, viral, mycoplasma, and endotoxin checks.
Before the procedure, the medical team explains what type of cells will be used, where they come from, and what quality-control documents are available.
For arthritis, cells are typically administered via the following:
- Intra-articular injection directly into the affected joint—often for stem cell therapy for knees, hips, and shoulders;
- Intravenous infusion of donor MSCs for systemic anti-inflammatory effects, particularly when multiple joints are involved.
Treatment typically involves a 3–9-day in-clinic program and may, in some cases, be followed by at-home maintenance using exosome-based products. Supportive therapies—physiotherapy, kinesiotherapy, shockwave, and IMR (intracellular metabolism recovery) drips—may be included to enhance the local tissue response.
Stem Cell Therapy for Arthritis: Patient Recovery, Rehabilitation, and Long-Term Follow-Up
Patients are never discharged the same day—there is always a short observation period. However, most patients return to normal daily activity quickly.
Our medical team stays in touch with patients for several months after treatment. A complimentary follow-up check-up, including accommodation, is usually offered 3–6 months later.
Stem Cell Therapy for Arthritis: Side Effects, Risks, and Safety Considerations
Like any medical procedure, stem cell injections may carry potential risks and side effects. However, when MSCs are prepared in a controlled laboratory and administered by experienced clinicians, treatment is generally well tolerated, with most reported side effects being mild and short-lived.
Safety in Swiss Medica
Want to know exactly how cell quality, sterility, and patient safety are controlled at each step?
See our article about stem cell therapy safety and side effects for a full breakdown.
What Side Effects Can Occur?
The most common side effects of stem cell therapy for arthritis are temporary and resolve within a few days:
- mild rise in body temperature for several hours;
- short-term fatigue;
- mild soreness or swelling at the injection or IV site;
- mild headache.
Most are managed with over-the-counter pain relief and do not require an extended stay.
Are There Serious Risks Patients Should Know About?
Any injection into a joint carries a small risk of infection (septic arthritis), which is why sterile preparation and trained operators are critical at every stage—from cell processing in the lab to the injection itself.
When considering stem cell treatment for arthritis, patients frequently ask two additional questions, partly because of the mixed information available outside clinical sources:
- immune rejection,
- long-term effects.
Immune rejection from donor MSCs is considered unlikely, because mesenchymal stromal cells have low immunogenicity — they do not strongly express the surface markers that typically trigger an immune response. This is one of the reasons allogeneic MSCs from umbilical cord and placental tissue are widely used in regenerative protocols.
As for long-term safety, the concern about tumor formation in stem cell therapy historically applies to embryonic stem cells, which Swiss Medica does not use. To date, no documented evidence links adult mesenchymal stromal cells to tumor formation when properly sourced, processed, and administered.
Questions to Ask Before Choosing a Stem Cell Clinic
Choosing a clinic for regenerative treatment is not a routine decision, and pricing alone is rarely the most informative comparison. The following questions help separate well-run programs from less reliable ones—and the answers reveal how seriously a clinic takes cell quality, patient safety, and long-term care:
- What type of cells are used, and where are they sourced?
- Where are the cells processed, and what quality control is in place?
- What outcomes are realistic for the specific condition?
- What follow-up is included after discharge?
How Much Does Stem Cell Therapy for Arthritis Cost?
The costs of stem cell therapy vary widely between countries, clinics, and treatment plans. Higher prices in Switzerland, the US, and the UK tend to reflect elevated operational expenses rather than a fundamental difference in the medical approach.
Typical Cost Range at Swiss Medica
Packages include medical evaluation, cell-based therapy, supportive procedures, accommodation, meals, airport transfers, and translation. Stem cell therapy costs typically range from €7,000 to €45,000* depending on the condition and personalized plan.
* Prices are indicative and based on 2026 estimates; they may vary depending on condition severity and required cell quantity.
Why Treatment Costs Can Differ
There is no single fixed price for arthritis treatment because each program is planned around the patient’s diagnosis, imaging results, general health, and treatment goals. The final price of stem cell therapy for arthritis may depend on:
- Specific condition and severity;
- Cell type and quantity required;
- Length of the in-clinic program (3–9 days standard);
- Supportive therapies included:
- Whether home maintenance with exosome-based products is recommended.
What to Consider When Comparing Clinics
A lower or higher price does not always show what the patient will actually receive. Before comparing treatment offers, it is important to check what is included in the package and how the clinic manages safety and follow-up. Key questions include the following:
- What exactly is included—medical fees only, or also accommodation, transfers, and follow-up?
- Are cells produced in-house or sourced externally?
- Is there a structured follow-up plan after patients return home?
Will Insurance Cover the Treatment?
Would you like to know if insurance can help with the costs of stem cell treatment for arthritis? Most insurers do not cover regenerative cell therapy, but coverage rules differ between countries, providers, and individual policies.
Dive deeper with our stem cell therapy insurance coverage article.
Why Patients Choose Swiss Medica for Stem Cell Treatment for Arthritis
Patients from 70+ countries have come to Swiss Medica in Belgrade for regenerative medicine for arthritis and other conditions. Our hospital is barrier-free and accessible for patients with reduced mobility, so moving around the clinic, attending procedures, and staying with an accompanying person is as convenient as possible.
Individual Medical Assessment
At Swiss Medica, treatment is built around established clinical protocols that are adapted to the patient’s diagnosis, stage of joint damage, general health, and treatment goals. Before recommending stem cell treatment for arthritis, our doctors review the case individually and explain whether there is a reasonable expectation of benefit.
When clinically appropriate, the program may also include supportive therapies such as physiotherapy, kinesiotherapy, medical device therapies, or IMR. These procedures are selected by the doctor to complement the regenerative treatment, support mobility, and make the recovery process safer and more comfortable.
In-House Laboratory and Quality Standards
Our cell products are developed and processed in our in-house stem cell laboratory, which meets EU GMP Grade A cleanliness standards. Keeping the process in-house eliminates risks associated with external labs or transport. Serbia provides a cost-effective environment for this care while meeting EU-aligned regulations.
Support for International Patients
Our English-speaking team coordinates travel, accommodation, airport transfers, and translation. Patients may bring one accompanying person, and meals are included.
Choosing a clinic abroad is not only about the treatment itself. Patients also need to know who will supervise their care, how the clinic is organized, what support is available during their stay, and how safety is managed at each stage. You can find all the answers you need in our separate article.
About Swiss MedicaSpeak With a Medical Advisor About Joint Pain
The next step for patients considering regenerative medicine for arthritis is a free medical consultation.
Contact us
Our doctors will review your medical history, explain your options and help you understand what a personalized program might entail, with no obligation to proceed. Simply fill out the form below.
FAQ
1. Can stem cell therapy reverse arthritis?
No clinic can responsibly promise a complete reversal of arthritis. Stem cell therapy may help reduce pain and improve joint function for some patients, especially in early to moderate stages, but it does not regrow a worn-out joint or eliminate the underlying disease process.
2. How effective is stem cell therapy for arthritis?
Recent meta-analyses on knee osteoarthritis show improvements in pain and function for some patients at 6 and 12 months. Evidence remains variable in certainty, and individual outcomes depend on disease stage, cell type, dosage, and supportive care.
3. What are the negative side effects of stem cell therapy?
Most reported side effects are mild and short-lived: a brief rise in temperature, fatigue, mild headache, or soreness at the injection site. Serious adverse events are uncommon when treatment is performed under appropriate medical and laboratory standards.
4. How much does stem cell therapy for arthritis cost?
At Swiss Medica, packages typically range from €7,000 to €45,000* depending on the condition and the individualized plan. Prices in countries such as Switzerland, the US, and the UK are often higher due to operational and regulatory costs.
* Prices are indicative and based on 2026 estimates; they may vary depending on condition severity and required cell quantity.
5. Is stem cell therapy for arthritis FDA approved?
Mesenchymal stem cell injections for arthritis are not FDA-approved in the United States as a standard therapy, although some MSC-based therapies have received regulatory approvals in certain countries and the field continues to develop. Swiss Medica provides treatment outside the US, under the regulatory framework of the countries where our clinics operate.
6. Can stem cell therapy help knee arthritis?
Knee osteoarthritis is the most studied indication. Several randomized trials and meta-analyses report symptomatic improvement after intra-articular MSC injections.
7. Can stem cell therapy help hip arthritis?
Hip osteoarthritis is also commonly treated and treatment plans are tailored to the individual based on imaging, symptoms, and overall health.
8. How long does it take to feel results after treatment?
After stem cell therapy for arthritis, patients may see first changes within a few months. More substantial improvements in pain and function usually emerge gradually over the next 3-6 months. The answer depends on the stage of the disease and individual factors.
9. Who is not a suitable candidate for arthritis stem cell treatment?
Patients with very advanced joint destruction clearly requiring surgery, active joint infection, active malignancy, pregnancy, or uncontrolled systemic conditions are generally not suitable. Our medical team reviews each case individually before making any decision.
10. Can stem cell therapy help avoid joint replacement surgery?
In some patients with moderate disease, stem cell treatment for arthritis may reduce symptoms enough to postpone surgery. It does not guarantee that joint replacement can be avoided permanently, and the decision should always involve the patient’s orthopedic specialist.
List of References:
Whittle SL, Johnston RV, McDonald S, et al. Stem cell injections for osteoarthritis of the knee. Cochrane Database of Systematic Reviews. 2025;4(4):CD013342. https://pubmed.ncbi.nlm.nih.gov/40169165/
Cao M, Ou Z, Sheng R, et al. Efficacy and safety of mesenchymal stem cells in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Research & Therapy. 2025;16(1):122. https://pubmed.ncbi.nlm.nih.gov/40055739/
Wang J, Xue H, Shi M, Chen R. Mesenchymal stem cell-based therapy for osteoarthritis: a systematic review and meta-analysis of clinical outcomes and functional recovery. Front Cell Dev Biol. 2026 Jan 6;13:1746471. https://pubmed.ncbi.nlm.nih.gov/41567976/
Zeng L, Liu C, Wu Y, et al. Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials. Stem Cell Research & Therapy. 2025;16(1):65. https://doi.org/10.1186/s13287-025-04184-x
Chen X, Zheng J, Yin L, Li Y, Liu H. Transplantation of three mesenchymal stem cells for knee osteoarthritis, which cell and type are more beneficial? A systematic review and network meta-analysis. Journal of Orthopaedic Surgery and Research. 2024;19(1):366. https://doi.org/10.1186/s13018-024-04846-1
Medical Advisor, Swiss Medica doctor
